Market News | Nirvana Systems Inc. - Part 2

Category Archives for "Market News"

Sustainable Footwear Brand VIVAIA Launches Free Trial Worldwide

VIVAIA, an up-and-coming brand of eco-friendly footwear, has launched a “New Product Testers Wanted“ campaign on November 24th, 2020.  MIAMI, Nov. 24, 2020 /PRNewswire/ — “Sustainable, stylish, step into conscious comfort.” Bearing this vision in mind, VIVAIA focuses on creating a positive impact on both the environment and people. Applying recycled materials, VIVAIA has established […]

Continue reading

Home Searches in Cities Up 200% From Last Year, Reflecting Renewed Interest in Urban Areas After Pandemic-Driven Drop

SEATTLE, Nov. 24, 2020 /PRNewswire/ — (NASDAQ:RDFN) — Pageviews of homes in rural areas increased 235% year over year in October, a large increase but still a deceleration from a 273% peak in August, according to a new report from Redfin (www.redfin.com), the technology-powered real estate brokerage. The story is similar in small towns, where pageviews rose… Read […]

Continue reading

Rocket Lab recovers booster after launch in major step toward reusing its small rockets

An Electron rocket gets ready to launch. Rocket Lab Rocket Lab, the leading company building and launching small rockets, on Thursday took what CEO Peter Beck described as a “huge milestone” in its work to reuse rockets. The company recovered the booster of its Electron rocket after it splashed down in the Pacific Ocean. The… […]

Continue reading

JPMorgan becomes first major bank to say first-quarter GDP will decline because of Covid surge

Volunteers from women’s organization Nuevo Amanecer Mujer Integral help with the distribution of frozen turkeys and food boxes ahead of Thanksgiving to families affected by the Covid-19 pandemic on November 18, 2020 in Los Angeles, California. Frederic J. Brown | AFP | Getty Images JP Morgan economists now see an economic contraction in the first… Read […]

Continue reading

What to expect after the Oxford-AstraZeneca COVID-19 vaccine news

U.K.-based drugmaker AstraZeneca AZN, -3.81% said on Monday that the coronavirus vaccine it is developing with the University of Oxford had shown an average efficacy of 70% in the Phase 3 trials, and that it would “immediately prepare regulatory submission” of the data for approval by regulatory authorities around the world, for conditional or early […]

Continue reading
>